Invasive pneumococcal diseases in children aged 1-59 months in sicily, Italy: Importance of active family paediatrician surveillance and vaccination coverage

EuroMediterranean Biomedical Journal

Volumn 9, Issue , 2014, Pages 19-23

  Amodio, Emanuele ^a   Costantino, Claudio ^a   Giuffrè, Mario ^a   Piccione, Maria ^a   Tramuto, Fabio ^a   Vitale, Francesco ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894343300     PISSN: 22797165     EISSN: None     Source Type: Journal    
DOI: 10.3269/1970-5492.2014.9.3     Document Type: Article

References (13)

1. Melegaro A, Edmunds WJ, Pebody R, Miller E, George R. The current burden of pneumococcal disease in England and Wales. J Infect. 2006;52:37-48.
2. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulhol-land K, Levine OS, Cherian T. Hib and Pneu-mococcal Global Burden of Disease Study Team. Burden of disease caused by Strep-tococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009 Sep 12;374(9693):893-902. Review.
3. World Health Organization Pneumococ-cal conjugate vaccine for childhood immu-nization - WHO position paper. Wkly Epide-miol Rec. 2007;82:93-104.
4. Piano Nazionale Vaccini 2005-2007. Available on http://www.salute.gov.it/imgs/C_17_pubblicazioni_543_allegato.pdf, accessed 10/10/2012.
5. ISTAT. Available at http://www.istat.it/it/sicilia/dati?q=gettable&dataset=DCIS_ASSBASE&dim=120,0,0&lang=2&tr=0&te=1
6. Whitney CG, Farley MM, Hadler J, Harri-son LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Fack-lam RR, Jorgensen JH, Schuchat A. Active Bacterial Core Surveillance of the Emerging Infections Program Network Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737-1746.
7. Italian National Institute of Health. Pro-tocollo per la sorveglianza nazionale delle malattie invasive da meningococco, pneumococco ed emofilo in Italia. 2007. Available at http://www.salute.gov.it/imgs/C_17_pubblicazioni_744_allegato.pdf, last access on 12/31/2013.
8. Nicolotti N, Gualano MR, Kheiraoui F, Castiglia P, Pessina EA, Ricciardi W, La Torre G. Introduction of a new vaccine in the context of Italian and regional preven-tion. Italian Journal of Public Health. Vol-ume 6, Issue 4 SUPPL. 5, 2009, Pages 34-51. Available at http://www.ijph.it/pdf/27/034.pdf
9. D'Ancona F, Salmaso S, Barale A, Boccia D, Lopalco PL, Rizzo C, Monaco M, Massari M, Demicheli V, Pantosti A, Italian PNC-Euro working group. Incidence of vaccine preventable pneumococcal invasive infec-tions and blood culture practices in Italy. Vaccine 2005, 23:2494-2500.
10. Riva E, Salvini F, Garlaschi ML, Radaelli G, Giovannini M. The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy. BMC Infect Dis. 2012 May 3 and 12:106.
11. Dagan R, Patterson S, Juergens C, Greenberg D, Givon-Lavi N, Porat N, Gurt-man A, Gruber WC, Scott DA. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colo-nization: a randomized double-blind trial.Clin Infect Dis. 2013 Oct;57(7):952-962.
12. Fleming-Dutra KE, Conklin L, Loo JD, Knoll MD, Park DE, Kirk J, Goldblatt D, Whitney CG, O'Brien KL. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage. Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S152-60.
13. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011 Dec 3;378(9807):1962-1973.